Actual Medicinal Product (AMP) Naprosyn EC 375mg tablets (Atnahs Pharma UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Light sensitive medicine. Store in light resistant container.   Manufacturer recommends storing in original container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Naprosyn EC 375mg Gastro-Resistant tablets (Atnahs Pharma UK Ltd) and naproxen 375mg Gastro-resistant tablets (Accord-UK Ltd).

Generic
Naproxen
Formulation
Naproxen 375mg gastro-resistant tablets
  • Naproxen
    • Naproxen 375mg gastro-resistant tablets

      • Naprosyn EC 375mg tablets (Atnahs Pharma UK Ltd)